Manufacturers Life Insurance Company, The Cabaletta Bio, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 56,271 shares of CABA stock, worth $115,918. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,271
Previous 55,864
0.73%
Holding current value
$115,918
Previous $263,000
53.23%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CABA
# of Institutions
115Shares Held
39.6MCall Options Held
297KPut Options Held
98.6K-
Black Rock Inc. New York, NY4.76MShares$9.8 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.07MShares$8.39 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$7.49 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$5.91 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$5.69 Million1.64% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $59.8M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...